Tibra Equities Europe’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,900	Closed	-$221K	–	260
2019 Q2	$221K	Buy	+10,900	New	+$221K	0.02%	225